Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Practice Management Information Center

US Plans on COVID-19 Booster Shots as Soon as September

Diana Ernst, RPh

August 18, 2021

Americans will be able to start getting a booster of the mRNA COVID-19 vaccine starting September 20, 2021.

Infectious Diseases Information Center

CDC Reverses Course on Masks for Fully Vaccinated in Light of SARS-CoV-2 Variants

Diana Ernst, RPh

August 3, 2021

The CDC also issued a health advisory about the urgent need to increase COVID-19 vaccination coverage.

Infectious Diseases Information Center

Baricitinib Alone Authorized for COVID-19 Under Revised EUA

Diana Ernst, RPh

July 30, 2021

The update was based on data from the COV-BARRIER study.

Neurology Information Center

Aduhelm Gets Accelerated Approval for Alzheimer Disease

Diana Ernst, RPh

June 9, 2021

The treatment, which is administered as a monthly intravenous infusion, binds to aggregated β-amyloid and promotes removal of amyloid from the brain.

Infectious Diseases Information Center

Artesunate for Injection Now Available for Severe Malaria

Diana Ernst, RPh

April 12, 2021

Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains.